Cargando…

Effects of increased body weight and short-term weight loss on serum PCSK9 levels – a prospective pilot study

INTRODUCTION: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is associated with low-density lipoprotein (LDL) catabolism, but its serum concentration is not uniformly associated with cardiovascular disease in clinical studies. Obesity is linked with increased cardiovascular risk, but the effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Filippatos, Theodosios D, Liberopoulos, Evangelos, Georgoula, Maria, Tellis, Constantinos C, Tselepis, Alexandros D, Elisaf, Moses
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2017
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728080/ https://www.ncbi.nlm.nih.gov/pubmed/29242844 http://dx.doi.org/10.5114/amsad.2017.70502

Ejemplares similares

Vitamin D status and cardiometabolic risk factors in Greek adolescents with obesity – the effect of vitamin D supplementation: a pilot study
por: Makariou, Stefania E., et al.
Publicado: (2020)

The effect of combining rosuvastatin with sartans of different peroxisome proliferator receptor-γ activating capacity on plasma 8-isoprostane prostaglandin F(2a) levels
por: Rizos, Christos V., et al.
Publicado: (2013)

PCSK9 and carbohydrate metabolism: A double-edged sword
por: Filippatos, Theodosios D, et al.
Publicado: (2017)

PCSK9 is minimally associated with HDL but impairs the anti-atherosclerotic HDL effects on endothelial cell activation
por: Dafnis, Ioannis, et al.
Publicado: (2022)

Effects of Eprosartan on Serum Metabolic Parameters in Patients with Essential Hypertension
por: Rizos, Evangelos C, et al.
Publicado: (2007)

LDL cholesterol estimation in patients with the metabolic syndrome
por: Gazi, Irene, et al.
Publicado: (2006)

Association between PCSK9 Levels and Markers of Inflammation, Oxidative Stress, and Endothelial Dysfunction in a Population of Nondialysis Chronic Kidney Disease Patients
por: Dounousi, Evangelia, et al.
Publicado: (2021)

Thiazide–associated hyponatremia in the elderly: what the clinician needs to know
por: Liamis, George, et al.
Publicado: (2016)

Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?
por: Filippatos, Theodosios D., et al.
Publicado: (2017)

Effects of Angiopoietin-Like 3 on Triglyceride Regulation, Glucose Homeostasis, and Diabetes
por: Christopoulou, Eliza, et al.
Publicado: (2019)

Non-hemorrhage-related adverse effects of rivaroxaban
por: Christopoulou, Eliza C., et al.
Publicado: (2017)

Hyponatremia in the elderly: challenges and solutions
por: Filippatos, Theodosios D, et al.
Publicado: (2017)

Differential pharmacology and clinical utility of dapagliflozin in type 2 diabetes
por: Papakitsou, Ioanna, et al.
Publicado: (2019)

Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?
por: Barkas, Fotios, et al.
Publicado: (2021)

Life-threatening hypophosphataemia in a cirrhotic patient with jaundice
por: Moutzouri, Elisavet, et al.
Publicado: (2011)

No effect of vitamin D supplementation on cardiovascular risk factors in subjects with metabolic syndrome: a pilot randomised study
por: Makariou, Stefania E., et al.
Publicado: (2017)

Electrolyte and acid-base disorders in inflammatory bowel disease
por: Barkas, Fotis, et al.
Publicado: (2013)

No effect of fenugreek, bergamot and olive leaf extract on glucose homeostasis in patients with prediabetes: a randomized double-blind placebo-controlled study
por: Florentin, Matilda, et al.
Publicado: (2019)

Significant Weight Loss in a Patient Taking Olmesartan: An Unusual Case Report
por: Makri, Andromachi, et al.
Publicado: (2019)

Differences in metabolic parameters and cardiovascular risk between American Diabetes Association and World Health Organization definition of impaired fasting glucose in European Caucasian subjects: a cross-sectional study
por: Filippatos, Theodosios D., et al.
Publicado: (2013)

Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized Study
por: Kei, Anastazia, et al.
Publicado: (2011)

Attainment of multifactorial treatment targets among the elderly in a lipid clinic
por: Barkas, Fotios, et al.
Publicado: (2015)

Statin escape phenomenon: Fact or fiction?
por: Barkas, Fotios, et al.
Publicado: (2017)

Lipoprotein(a), Interleukin-6 inhibitors, and atherosclerotic cardiovascular disease: Is there an association?
por: Makris, Anastasios, et al.
Publicado: (2023)

Fenofibrate in Primary Biliary Cirrhosis: A Pilot Study
por: Liberopoulos, E.N, et al.
Publicado: (2010)

Differential effects of PCSK9 loss of function variants on serum lipid and PCSK9 levels in Caucasian and African Canadian populations
por: Mayne, Janice, et al.
Publicado: (2013)

Effect of Plant Polyphenols on Adipokine Secretion from Human SGBS Adipocytes
por: Derdemezis, Christos S., et al.
Publicado: (2011)

The relationship of vitamin D with non-traditional risk factors for cardiovascular disease in subjects with metabolic syndrome
por: Makariou, Stefania, et al.
Publicado: (2012)

Sleep Deprivation: Effects on Weight Loss and Weight Loss Maintenance
por: Papatriantafyllou, Evangelia, et al.
Publicado: (2022)

Comparative effectiveness of guided weight loss and physical activity monitoring for weight loss and metabolic risks: A pilot study
por: Peyer, Karissa L., et al.
Publicado: (2017)

PCSK9 and Atherosclerosis - Lipids and Beyond
por: Shapiro, Michael D., et al.
Publicado: (2017)

FOURIER & PCSK9 RNAi: Towards enhancing durability and efficacy of PCSK9 inhibitors
por: Hassan, Mohamed
Publicado: (2017)

The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol
por: Seidah, Nabil G.
Publicado: (2017)

A Review of Time Courses and Predictors of Lipid Changes with Fenofibric Acid-Statin Combination
por: Filippatos, Theodosios D.
Publicado: (2012)

Development of a Novel Apigenin Dosage form as a Substitute for the Modern Triple Antithrombotic Regimen
por: Tsiailanis, Antonios D., et al.
Publicado: (2023)

Weight Loss Trajectory Patterns and Short-Term Prediction in a Weight Management Program
por: Zhou, Bingjie, et al.
Publicado: (2022)

Weight loss and weight gain among participants in a community-based weight loss Challenge
por: Funk, Merrill D., et al.
Publicado: (2019)

The Multifaceted Biology of PCSK9
por: Seidah, Nabil G, et al.
Publicado: (2021)

The PCSK9 Problem: Is it Predictive, Punitive, or Puzzling?
por: Pamir, Nathalie, et al.
Publicado: (2021)

Psychological and weight history variables as predictors of short‐term weight and body fat mass loss
por: Akter, Sharmin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p5u91nnhstdj9g7shjp8s90cuh